Manifold MarketsSans KYCDonnées de résolution vérifiéesAssez bien calibréPrévision communautaire actuelleNon 96%
Prévisionnistes
39
Type de question
binary
Méthodologie
Play-money forecasting platform
Type de source
Prévision
Données du marché
Mis à jour il y a 13 heures
Obsolète8 mai 26, 22:38 UTC31 déc. 26, 23:59 UTC
Tendances
Marchés Associés
Questions liées pour le contexte, et non une comparaison de contrats équivalents.
Règles
This question will be resolved alongside the corresponding market on Polymarket: https://polymarket.com/event/hantavirus-vaccine-in-2026
- Resolution criteria
- This market will resolve to "Yes" if any vaccine intended for humans and inoculating against Hantavirus (including Hantavirus Pulmonary Syndrome (HPS) or Hemorrhagic Fever with Renal Syndrome (HFRS)) receives full approval from the U.S. Food and Drug Administration between market creation and December 31, 2026, 11:59 PM ET.
- Otherwise, this market will resolve to "No".
- The primary resolution source for this market will be official information from the FDA, including its list of approved vaccines (https://www.fda.gov/vaccines-blood-biologics/vaccines/vaccines-licensed-use-united-states), however a consensus of credible reporting may also be used.
- Hantaviruses are a family of viruses spread mainly by rodents and can cause varied disease syndromes in people worldwide.